CELH
Celsius Holdings, Inc.
CELH has the edge over EL overall, supported by stronger valuation and stronger fundamentals.
EL
The Estée Lauder Companies Inc.
EL has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
EL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
EL's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over EL in the historical PE scenario, which offers more potential upside but is not a forecast.
EL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 31x | $111 | — |
| Cheap | 37x | $37.64 | -66% |
| Fair | 59x | $59.97 | -46% |
| Current | 109x | $111 | — |
| Expensive | 118x | $119 | +7.5% |
Historical ranges are pointers, not guarantees.
EL's PE is in its expensive range at 109x. If earnings grow as analysts expect, today's price would be 31x next year's earnings, in its cheap range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
EL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for EL, with profitability improving.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
EL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.54 | +251% |
| Q3 2026 | $1.01 | +$3.60 |
| Q2 2026 | $0.50 | +$3.65 |
| Q1 2026 | -$0.71 | +$1.71 |
| Q4 2025 | -$0.51 | +$1.44 |
| Q3 2025 | -$2.59 | -562% |
| Q2 2025 | -$3.15 | -392% |
| Q1 2025 | -$2.42 | -235% |
| Q4 2024 | -$1.95 | -249% |
EL has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over EL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over EL on profitability, with a higher operating margin.
EL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +6.7% |
| Q2 2026 | $3.6B | +6.3% |
| Q1 2026 | $3.7B | +4.6% |
| Q4 2025 | $4.2B | +5.6% |
| Q3 2025 | $3.5B | +3.6% |
| Q2 2025 | $3.4B | -12% |
| Q1 2025 | $3.6B | -9.9% |
| Q4 2024 | $4B | -6.4% |
EL's revenue is recovering but still below its 2021 peak: $3.7B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +6.1 points |
| Q2 2026 | -1.1% | +10 points |
| Q1 2026 | 6.7% | -1.9 points |
| Q4 2025 | 9.5% | +24 points |
| Q3 2025 | 4.8% | +8.4 points |
| Q2 2025 | -11% | -5.4 points |
| Q1 2025 | 8.6% | -4.9 points |
| Q4 2024 | -14% | -28 points |
EL's operating margin was 11% last quarter, up 6.1 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
EL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$235M | +$201M |
| Q2 2026 | $425M | +7.9% |
| Q1 2026 | $310M | +91% |
| Q4 2025 | $1B | +9.9% |
| Q3 2025 | -$436M | +$375M |
| Q2 2025 | $394M | -41% |
| Q1 2025 | $162M | -55% |
| Q4 2024 | $925M | -17% |
EL has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over EL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
EL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.3M shares |
| 1 year | +0.8% | +2.8M shares |
| 3 years | +1.6% | +5.6M shares |
| 5 years | -0.5% | -1.8M shares |
| Available history | -0.2% | -600K shares |
EL has 366M diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1M |
| Q2 2026 | — |
| Q1 2026 | $3M |
| Q4 2025 | $58M |
| Q3 2025 | $9M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $25M |
EL spent $62M buying back its own shares over the past year, up 82% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over EL on leverage, with a lower net debt burden relative to earnings.
EL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 3.0x | Moderate |
| Q4 2025 | 3.3x | Elevated |
| Q3 2025 | 15.7x | High |
| Q2 2025 | 99.9x | High |
| Q1 2025 | 23.1x | High |
| Q4 2024 | 10.9x | High |
EL's net debt is about 2.0 years of its operating earnings (EBITDA), down from 16 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
EL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.6 | Neutral |
| Stochastic | 87.2 | Overbought |
EL's weekly RSI is 65 (neutral) and its Stochastic is 87 (overbought).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over EL on valuation relative to its sector.
EL PE vs Consumer Defensive Sector
| Metric | EL | Sector median | Relative |
|---|---|---|---|
| PE | 109x | 19x | 461% above |
| PE % | 75 | 18 | 57 pts above |
EL is trading at 109x earnings, a 461% premium to the Consumer Defensive sector's median of 19x.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
EL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $103.4 | 6.8% above |
| 20 week MA | $95.7 | 15% above |
| 50 week MA | $94.6 | 17% above |
| 100 week MA | $86.4 | 28% above |
| 200 week MA | $118.3 | 6.6% below |
EL has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
EL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.0 | $261.0 | +25% |
| 2021 | $261.0 | $366.0 | +40% |
| 2022 | $366.0 | $241.0 | -34% |
| 2023 | $241.0 | $146.3 | -39% |
| 2024 | $146.3 | $74.6 | -49% |
| 2025 | $74.6 | $107.7 | +44% |
| 2026 YTD | $107.7 | $110.5 | +2.7% |
EL has the edge over CELH on returns for 2026, with the stronger performance.